Bridgepoint Group plc (LON:BPT – Get Free Report)’s share price reached a new 52-week low on Monday . The stock traded as low as GBX 218.40 and last traded at GBX 218.40, with a volume of 7927679 shares traded. The stock had previously closed at GBX 226.60.
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. upped their price target on shares of Bridgepoint Group from GBX 395 to GBX 415 and gave the company a “buy” rating in a research report on Monday, January 5th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, Bridgepoint Group presently has an average rating of “Moderate Buy” and an average target price of GBX 385.
Read Our Latest Analysis on Bridgepoint Group
Bridgepoint Group Trading Down 4.0%
Bridgepoint Group (LON:BPT – Get Free Report) last issued its quarterly earnings data on Thursday, March 12th. The company reported GBX 26.50 EPS for the quarter. Bridgepoint Group had a net margin of 7.68% and a return on equity of 4.25%. Analysts predict that Bridgepoint Group plc will post 17.4062165 earnings per share for the current fiscal year.
Insider Activity
In related news, insider Michelle Scrimgeour purchased 21,616 shares of the firm’s stock in a transaction that occurred on Thursday, March 12th. The stock was bought at an average cost of GBX 230 per share, with a total value of £49,716.80. 0.60% of the stock is owned by corporate insiders.
About Bridgepoint Group
Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
Featured Stories
Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.
